Mommy’s Bliss Nipple Cream Recall

Mommy’s Bliss Nipple Cream has been removed from the market because certain ingredients contained in the product could be harmful to nursing infants. On Friday, the FDA issued a warning for mothers not to use the nipple cream and to seek immediate medical care if their baby experiences problems such as respiratory distress, vomiting or diarrhea.

The recalled nipple cream was marketed by California based MOM Enterprises, Inc. to help nursing mothers soothe and heal dry or cracked nipples. Although the label specifically states that there is no need to remove the cream before nursing, the FDA indicates that two of the ingredients could pose a serious health risk. The Mommy’s Bliss Nipple Cream contains chlorphenesin and phenoxyethanol, which could depress the central nervous system, cause repiratory depression or vomiting and diarrhea, which can lead to dehydration for infants.

“The FDA is particularly concerned that nursing infants are being unwittingly exposed by their mothers to this product with dangerous side effects,” said FDA official Janet Woodcock, M.D.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Some of the symptoms of problems which could be caused by the recalled nipple cream include:

  • Vomiting
  • Diarrhea
  • Dehydration
  • Respiratory Depression (slow or shallow breathing)
  • Difficulty Waking
  • Limp Extremities
  • Decreased Strength of Grip
  • Skin Color Changes

Any users who have experienced side effects from the Mommy’s Bliss Nipple Cream have been asked to report adverse events to the FDA’s MedWatch at (800) 332-10800 or on the internet at http://www.fda.gov/medwatch/report.htm.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Lawsuit MDL Application Will Be Considered by JPML at Hearing on Jan. 30, 2025
Depo-Provera Lawsuit MDL Application Will Be Considered by JPML at Hearing on Jan. 30, 2025 (Posted 4 days ago)

With a growing number of women pursuing Depo-Provera brain tumor lawsuits throughout the federal court system, the U.S. JPML will decide whether to consolidate and centralize the claims before one judge for coordinated discovery and pretrial proceedings.